Custom-designed MLPA using multiple short synthetic probes: Application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancer

Journal of Molecular Diagnostics

Volumn 12, Issue 4, 2010, Pages 402-408

  Serizawa, Reza R ^a,b   Ralfkiær, Ulrik ^a   Dahl, Christina ^a   Lam, Gitte W ^b   Hansen, Alastair B ^b   Steven, Kenneth ^b   Horn, Thomas ^b   Guldberg, Per ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

POLYDEOXYRIBONUCLEOTIDE SYNTHASE; DNA PROBE;

ADULT; AGED; AMPLICON; ARTICLE; BLADDER CANCER; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA DETERMINATION; DNA TEMPLATE; FEMALE; GENE SEQUENCE; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METHYLATION; MULTIPLE SHORT SYNTHETIC PROBE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PROMOTER REGION; URINALYSIS; BLADDER TUMOR; DNA METHYLATION; DNA PROBE; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION; PROCEDURES; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE; URINE;

CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA PROBES; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 77954350151     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2010.090152     Document Type: Article

References (27)

1. Whiteley NM, Hunkapiller MW, and Glazer AN, inventors: Applied Biosystems, Inc. assignee 1989. Detection of specific sequences in nucleic acids. United States Patent US 4883750
2. Landegren U, Kaiser R, Sanders J, Hood L: A ligase-mediated gene detection technique. Science 1988, 241:1077-1080
3. Nickerson DA, Kaiser R, Lappin S, Stewart J, Hood L, Landegren U: Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci USA 1990, 87:8923-8927 (Pubitemid 120007621)
4. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30:e57
5. Nygren AO, Ameziane N, Duarte HM, Vijzelaar RN, Waisfisz Q, Hess CJ, Schouten JP, Errami A: Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 2005, 33:e128 (Pubitemid 41222585)
6. Dahl C, Guldberg P: A ligation assay for multiplex analysis of CpG methylation using bisulfite-treated DNA. Nucleic Acids Res 2007, 35:e144
7. Nilsson M, Barbany G, Antson DO, Gertow K, Landegren U: Enhanced detection and distinction of RNA by enzymatic probe ligation. Nature Biotechnol 2000, 18:791-793 (Pubitemid 30460700)
8. Bhagwat AS, Sanderson RJ, Lindahl T: Delayed DNA joining at 3′ mismatches by human DNA ligases. Nucleic Acids Res 1999, 27:4028-4033
9. Lu J, Tong J, Feng H, Huang J, Afonso CL, Rock DL, Barany F, Cao W: Unique ligation properties of eukaryotic NAD+-dependent DNA ligase from Melanoplus sanguinipes entomopoxvirus. Biochim Biophys Acta 2004, 1701:37-48
10. Barany F: Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci USA 1991, 88:189-193
11. Kozlowski P, Jasinska AJ, Kwiatkowski DJ: New applications and developments in the use of multiplex ligation-dependent probe amplification. Electrophoresis 2008, 29:4627-4636
12. Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van CW, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D: Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst 2006, 98:996-1004
13. Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R: Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 2006, 12:2109-2116
14. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R: Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res 2006, 12:383-391
15. Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, Fromont G, Sibony M, Cussenot O, Meuth M, Hamdy FC: Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 2005, 23:2903-2910
16. Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD, Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones PA, Liang G: Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin Cancer Res 2004, 10:7457-7465
17. Dulaimi E, Uzzo RG, Greenberg RE, Al-Saleem T, Cairns P: Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res 2004, 10:1887-1893 (Pubitemid 38375544)
18. Clark SJ, Harrison J, Paul CL, Frommer M: High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994, 22:2990-2997 (Pubitemid 24260626)
19. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28:E32
20. Worm J, Aggerholm A, Guldberg P: In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2001, 47:1183-1189 (Pubitemid 32579104)
21. Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B, Gazdar AF: Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 2001, 61:8659-8663
22. Chapman EJ, Harnden P, Chambers P, Johnston C, Knowles MA: Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype. Clin Cancer Res 2005, 11:5740-5747 (Pubitemid 41170298)
23. Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach D, Cordon-Cardo C: Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst 1995, 87:1524-1529
24. Stern RF, Roberts RG, Mann K, Yau SC, Berg J, Ogilvie CM: Multiplex ligation-dependent probe amplification using a completely synthetic probe set. Biotechniques 2004, 37:399-405 (Pubitemid 39180913)
25. Kozlowski P, Roberts P, Dabora S, Franz D, Bissler J, Northrup H, Au KS, Lazarus R, Domanska-Pakiela D, Kotulska K, Jozwiak S, Kwiatkowski DJ: Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 2007, 121:389-400
26. Dahl C, Guldberg P: DNA methylation analysis techniques. Biogerontology 2003, 4:233-250
27. Yates DR, Rehman I, Abbod MF, Meuth M, Cross SS, Linkens DA, Hamdy FC, Catto JW: Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 2007, 13:2046-2053